This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
July 12, 2018
Interim Report Q2 2018
July 11, 2018
Altimmune Appoints Mitchel Sayare as Executive Chairman of the Board, and Adds José Ochoa to Its Leadership Team as Chief Business Officer
July 05, 2018
Håkan Johansson to start as BONESUPPORT’s CFO at the end of 2018
July 03, 2018
Vicore Pharma and HealthCap create a leading drug development company focused on severe lung diseases
June 29, 2018
FDA APPROVES ZEPHYR ENDOBRONCHIAL VALVE FOR TREATING SEVERE EMPHYSEMA
June 27, 2018
Carisma Therapeutics Announces a $53 Million Series A Financing to Develop Novel CAR Macrophage Cellular Immunotherapy
June 26, 2018
BioClin Therapeutics Appoints Scott Myers as Chairman to its Board of Directors
June 25, 2018
Nordic Nanovector Appoints Eduardo Bravo as Chief Executive Officer
June 22, 2018
Altimmune Restructures Financing Agreement
June 21, 2018
Nordic Nanovector Announces First Patient Dosed in Pivotal PARADIGME Trial of Betalutin® in Third-line Follicular Lymphoma Patients